makers of semaglutide Apotex Gets Approval to Sell Generic in Canada | Chris Hannay posted on the topic Wegovy maker ends partnership with

Tirzepatide generally produces greater average weight loss in clinical studies, while semaglutide has a longer history of use and remains a popular option for many patients

While these side effects are usually manageable and not severe, patients are advised to communicate any persistent or troublesome symptoms to their healthcare provider to ensure proper management and care

These drugs are also being tested to treat other conditions, and the FDA has just approved a new use for Wegovy to reduce the risk of adverse cardiovascular events

However, if they stop slowly, and have expanded their awareness and understanding of healthy lifestyle behaviours and eating habits, their hunger and satiety will be more manageable, making it easier for them to maintain a healthy weight

doi: 10.3390/vaccines9040393